Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

ICU Topicsgi-nutrition

ICU · gi-nutrition

Acute-on-Chronic Liver Failure (ACLF) — Comprehensive ICU Management

Also known as ACLF · Acute-on-chronic liver failure · Acute decompensation of cirrhosis with organ failure · CLIF-C ACLF score · CANONIC criteria · Cirrhosis ICU

Acute-on-chronic liver failure (ACLF) — acute decompensation of cirrhosis complicated by organ failure(s) and high short-term mortality. In the CANONIC study, 28-day mortality was 33.9 percent in patients who had ACLF at enrolment versus 1.9 percent in those who never developed it, and grade of ACLF (number of organ failures) drives prognosis: with four or more organ failures and no transplant, 28-day mortality was 100 percent (CLIF cohort). Precipitants: bacterial infection (the most frequent associated factor) and severe alcohol-related hepatitis, identified or occult (EASL CPG 2023). Management: treat the precipitant, support failing organs, reverse hepatorenal-spectrum AKI with terlipressin plus albumin, give albumin 1.5 g per kg then 1 g per kg with antibiotics in spontaneous bacterial peritonitis, feed protein 1 to 1.5 g per kg per day rather than restricting it, and consider early liver transplantation — 1-year post-transplant survival 81 percent even in listed ACLF (ECLIS).

high19 referencesUpdated 8 Oct 202610 min readSource-verified · Oct 2026

Checked against its sources on 8 Oct 2026

Practise this topic

  • 8 MCQs

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • Cirrhosis patient + new organ failure (AKI, deep encephalopathy, vasopressor requirement) = ACLF — grade organ failures to stage severity
  • Grade 3 ACLF (three or more organ failures) carries the highest short-term mortality — 1-year waitlist survival was only 50 percent for ACLF-3 versus 73 percent for grades 1 to 2 in the ECLIS transplant cohort — so evaluate for liver transplant early
  • Bacterial infection is the dominant associated precipitant — cultures plus a diagnostic ascitic tap, then broad-spectrum antibiotics when infection is suspected (AGA best practice)
  • HRS-AKI is potentially reversible with terlipressin plus albumin — treat before tubules necrose; AKI in cirrhosis is creatinine rise of at least 0.3 mg per dL within 48 hours or at least 50 percent from baseline
  • Do NOT give platelets or FFP for procedures based on INR alone — cirrhosis has REBALANCED haemostasis (low procoagulants matched by low anticoagulants); PT/INR does not correspond to bleeding or clotting risk — use viscoelastic testing
On this page
Study tools

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • Cirrhosis patient + new organ failure (AKI, deep encephalopathy, vasopressor requirement) = ACLF — grade organ failures to stage severity
  • Grade 3 ACLF (three or more organ failures) carries the highest short-term mortality — 1-year waitlist survival was only 50 percent for ACLF-3 versus 73 percent for grades 1 to 2 in the ECLIS transplant cohort — so evaluate for liver transplant early
  • Bacterial infection is the dominant associated precipitant — cultures plus a diagnostic ascitic tap, then broad-spectrum antibiotics when infection is suspected (AGA best practice)
  • HRS-AKI is potentially reversible with terlipressin plus albumin — treat before tubules necrose; AKI in cirrhosis is creatinine rise of at least 0.3 mg per dL within 48 hours or at least 50 percent from baseline
  • Do NOT give platelets or FFP for procedures based on INR alone — cirrhosis has REBALANCED haemostasis (low procoagulants matched by low anticoagulants); PT/INR does not correspond to bleeding or clotting risk — use viscoelastic testing
The one-line answer

Acute-on-chronic liver failure (ACLF) is acute decompensation of cirrhosis complicated by organ failure and a high short-term mortality that simple decompensation does not share — in CANONIC, 28-day mortality was 33.9 percent with ACLF at enrolment versus 1.9 percent without it, and it climbs steeply with the number of failing organs. Bacterial infection is the dominant associated precipitant, so culture everything, tap the ascites, and start broad-spectrum antibiotics when infection is suspected. Hepatorenal-spectrum AKI is treated with terlipressin plus albumin. Do not chase the INR with FFP — cirrhosis is rebalanced haemostasis — and feed protein rather than restricting it. For grade 3 disease, involve the transplant service early: 1-year survival after transplant was 81 percent in the ECLIS cohort.

[1] [4] [13]

Meet the patient

A 52-year-old woman with NASH cirrhosis arrives septic and confused: three days of cough and rigors, now intubated for a creatinine of 240, bilirubin of 180, INR of 2.0, and a dense right lower-lobe pneumonia. She is on noradrenaline for a MAP of 57, lactate 4.8, West Haven grade II encephalopathy, tense ascites, and a PaO2 over FiO2 of 165 on the ventilator.[1]

The single question that frames her stay is whether this is decompensated cirrhosis that got worse, or ACLF — and the answer turns entirely on whether she has organ failure. Grade that, and the mortality, the transplant urgency, and the goals-of-care conversation all follow.[1]

ICU Fellowship (CICM) Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the ICU Fellowship (CICM) fellowship library.

Sign in to continueSee pricing
References19ShowHide
  1. [1]Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis Gastroenterology, 2013.PMID 23474284
  2. [2]Trebicka J, Fernandez J, Papp M, et al. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology J Hepatol, 2020.PMID 32673741
  3. [3]European Association for the Study of the Liver EASL Clinical Practice Guidelines on acute-on-chronic liver failure J Hepatol, 2023.PMID 37364789
  4. [4]Flamm SL, Wong F, Ahn J, et al. AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review Clin Gastroenterol Hepatol, 2022.PMID 36075500
  5. [5]Wong F, Pappas SC, Curry MP, et al. Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome N Engl J Med, 2021.PMID 33657294
  6. [6]Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis N Engl J Med, 1999.PMID 10432325
  7. [7]Bass NM, Mullen KD, Sanyal A, et al. Rifaximin treatment in hepatic encephalopathy N Engl J Med, 2010.PMID 20335583
  8. [8]Blei AT, Córdoba J Hepatic encephalopathy Am J Gastroenterol, 2001.PMID 11467622
  9. [9]Thursz M, Forrest E, Roderick P, et al. The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 x 2 factorial randomised controlled trial Health Technol Assess, 2015.PMID 26691209
  10. [10]Louvet A, Naveau S, Abdelnour M, et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids Hepatology, 2007.PMID 17518367
  11. [11]Jophlin LL, Singal AK, Bataller R, et al. ACG Clinical Guideline: Alcohol-Associated Liver Disease Am J Gastroenterol, 2024.PMID 38174913
  12. [12]Bañares R, Nevens F, Larsen FS, et al. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial Hepatology, 2013.PMID 23213075
  13. [13]Belli LS, Duvoux C, Artzner T, et al. Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS) J Hepatol, 2021.PMID 33951535
  14. [14]Gustot T, Fernandez J, Garcia E, et al. Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis Hepatology, 2015.PMID 25877702
  15. [15]Brower RG, Matthay MA, Morris A, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome N Engl J Med, 2000.PMID 10793162
  16. [16]Davis JPE, Northup PG, Caldwell SH, et al. Viscoelastic Testing in Liver Disease Semin Thromb Hemost, 2018.PMID 29469043
  17. [17]Córdoba J, López-Hellín J, Planas M, et al. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study J Hepatol, 2004.PMID 15246205
  18. [18]Br VK, Sarin SK Acute-on-chronic liver failure: Terminology, mechanisms and management. Clinical and molecular hepatology, 2023.PMID 36938601
  19. [19]Rashed E, Soldera J CLIF-SOFA and CLIF-C scores for the prognostication of acute-on-chronic liver failure and acute decompensation of cirrhosis: A systematic review. World journal of hepatology, 2022.PMID 36618331

Test yourself

Practise what you just read

  • 8 MCQs
ICU Fellowship (CICM) Pro

$29/ monthor $279 / year

The complete ICU Fellowship (CICM) library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousAcute-on-chronic liver failure (ACLF)GI/NutritionNextGI Bleeding, Pancreatitis, Hepatic Failure and NutritionGI & nutrition